Rifampicin inactivation by Bacillus species

Area of Science:

• Microbiology
• Antibiotic Resistance

Background:

• Rifampicin is a crucial antibiotic for treating various bacterial infections.
• Understanding mechanisms of antibiotic inactivation is vital for combating resistance.
• The role of specific bacterial species in rifampicin degradation remains incompletely understood.

Purpose of the Study:

• To investigate the capacity of different bacterial strains to inactivate rifampicin.
• To identify the mechanisms by which rifampicin inactivation occurs.
• To determine if phylogenetic relatedness influences the ability of bacteria to inactivate rifampicin.

Main Methods:

• Testing the ability of Bacillus, Staphylococcus, Pseudomonas, and Escherichia coli strains to inactivate rifampicin.
• Identifying inactivation mechanisms through biochemical analysis (phosphorylation and decolorization).

Main Results:

• Most tested Bacillus strains demonstrated the ability to inactivate rifampicin.
• Two distinct inactivation pathways were observed: phosphorylation and decolorization.
• No other tested bacterial genera (Staphylococcus, Pseudomonas, Escherichia coli) could inactivate rifampicin.
• The presence or absence of inactivation mechanisms did not correlate with bacterial phylogeny.

Conclusions:

• Bacillus species possess significant potential for rifampicin inactivation.
• Bacterial inactivation of rifampicin can occur via phosphorylation or decolorization, independent of phylogenetic relationships.
• The findings highlight Bacillus as a key player in rifampicin degradation, with implications for antibiotic stewardship and resistance monitoring.